Velan Capital Investment Management’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $14.5M | Hold |
6,986,744
| – | – | 14.29% | 1 |
|
2025
Q1 | $15.4M | Hold |
6,986,744
| – | – | 15.81% | 1 |
|
2024
Q4 | $10.7M | Hold |
6,986,744
| – | – | 9.22% | 3 |
|
2024
Q3 | $13.9M | Hold |
6,986,744
| – | – | 13% | 3 |
|
2024
Q2 | $24.5M | Hold |
6,986,744
| – | – | 14.01% | 3 |
|
2024
Q1 | $19.4M | Hold |
6,986,744
| – | – | 8.79% | 4 |
|
2023
Q4 | $11.9M | Hold |
6,986,744
| – | – | 6.93% | 2 |
|
2023
Q3 | $7.2M | Buy |
6,986,744
+2,486,744
| +55% | +$2.56M | 5.8% | 4 |
|
2023
Q2 | $5.22M | Hold |
4,500,000
| – | – | 4.85% | 6 |
|
2023
Q1 | $6.8M | Buy |
4,500,000
+2,000,000
| +80% | +$3.02M | 5.79% | 6 |
|
2022
Q4 | $6.25M | Buy |
+2,500,000
| New | +$6.25M | 5.52% | 7 |
|